Literature DB >> 9042123

Inhaled helium-oxygen revisited: effect of inhaled helium-oxygen during the treatment of status asthmaticus in children.

T M Kudukis1, C A Manthous, G A Schmidt, J B Hall, M E Wylam.   

Abstract

OBJECTIVES: To assess the effects of breathing a low-density gas mixture on dyspnea and the pulsus paradoxus in children with status asthmaticus.
DESIGN: In an urban academic tertiary referral center, 18 patients, aged 16 months to 16 years, who were being treated for status asthmaticus with continuously inhaled beta-agonist and intravenously administered methylprednisolone and had a pulsus paradoxus of greater than 15 mm Hg received either an 80%:20% helium-oxygen gas mixture (HELIOX patients) or room air (control patients) at 10 L/min by nonrebreathing face mask in a double-blind, randomized, controlled trial. In all patients, baseline data, including pulsus paradoxus (determined by sphygmomanometer or arterial catheter blood pressure readings), respiratory rate, heart rate, investigator-scored dyspnea index, and oxygen saturation, were compared with values obtained 15 minutes during and after intervention. In a subset of patients, peak flows before and after breathing HELIOX or room air were measured. When clinically indicated, arterial blood gases were obtained.
RESULTS: The pulsus paradoxus (in millimeters of mercury) fell significantly from an initial mean value of 23.3 +/- 6.8 to 10.6 +/- 2.8 with HELIOX breathing (p < 0.001) and increased again to 18.5 +/- 7.3 after cessation of HELIOX. Peak flow increased 69.4% +/- 12.8% during HELIOX breathing (p < 0.05). The dyspnea index decreased from an initial mean value of 5.7 +/- 1.3 to 1.9 +/- 1.7 with HELIOX breathing (p < 0.0002) and increased again to 4.0 +/- 0.5 after cessation of HELIOX breathing. In control patients, there was no significant difference in pulsus paradoxus or dyspnea index at any time during the study period. Mechanical ventilation was averted in three patients in whom dyspnea lessened dramatically during breathing of HELIOX.
CONCLUSION: During acute status asthmaticus, inhaled HELIOX significantly lowered the pulsus paradoxus, increased peak flow, and lessened the dyspnea index. Moreover, HELIOX spared three patients a planned intubation and caused no apparent side effects. Thus HELIOX reduces the work of breathing and may forestall respiratory failure in children with status asthmaticus, thus preventing the need for mechanical ventilation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9042123     DOI: 10.1016/s0022-3476(97)70346-9

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  16 in total

Review 1.  Pharmacologic management of the hospitalized pediatric asthma patient.

Authors:  K A Hardin; H J Kallas; R J McDonald
Journal:  Clin Rev Allergy Immunol       Date:  2001-06       Impact factor: 8.667

Review 2.  Management of acute pediatric asthma.

Authors:  John C Carl; Carolyn M Kercsmar
Journal:  Curr Allergy Asthma Rep       Date:  2002-11       Impact factor: 4.806

Review 3.  Drug therapy approaches in the treatment of acute severe asthma in hospitalised children.

Authors:  L K DeNicola; M O Gayle; K V Blake
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

4.  A neoprene vest hastens dyspnoea and leg fatigue during exercise testing: entangled breathing and cardiac hindrance?

Authors:  Jacques Regnard; Mathieu Veil-Picard; Malika Bouhaddi; Olivier Castagna
Journal:  Diving Hyperb Med       Date:  2021-12-20       Impact factor: 0.887

Review 5.  Heliox for treatment of exacerbations of chronic obstructive pulmonary disease.

Authors:  G Rodrigo; C Pollack; C Rodrigo; B Rowe
Journal:  Cochrane Database Syst Rev       Date:  2002

6.  Effects of helium-oxygen on respiratory mechanics, gas exchange, and ventilation-perfusion relationships in a porcine model of stable methacholine-induced bronchospasm.

Authors:  Christine Watremez; Giuseppe Liistro; Marc deKock; Jean Roeseler; Thierry Clerbaux; Bruno Detry; Marc Reynaert; Pierre Gianello; Philippe Jolliet
Journal:  Intensive Care Med       Date:  2003-05-16       Impact factor: 17.440

7.  Acute severe asthma: new approaches to assessment and treatment.

Authors:  Spyros A Papiris; Effrosyni D Manali; Likurgos Kolilekas; Christina Triantafillidou; Iraklis Tsangaris
Journal:  Drugs       Date:  2009       Impact factor: 9.546

8.  Ventilated Patients With COVID-19 Show Airflow Obstruction.

Authors:  Vikas S Koppurapu; Maksym Puliaiev; Kevin C Doerschug; Gregory A Schmidt
Journal:  J Intensive Care Med       Date:  2021-03-11       Impact factor: 3.510

9.  Application of medical gases in the field of neurobiology.

Authors:  Wenwu Liu; Nikan Khatibi; Aishwarya Sridharan; John H Zhang
Journal:  Med Gas Res       Date:  2011-06-27

Review 10.  Paediatrics: how to manage acute asthma exacerbations.

Authors:  James S Leung
Journal:  Drugs Context       Date:  2021-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.